《TAIPEI TIMES》 GBC seeks US authorization for oral COVID-19 drug - 焦點

By Kao Shih-ching / Staff reporterGolden Biotechnology Corp （GBC, 國鼎） plans to apply for emergency use authorization in the US for its experimental COVID-19 drug after positive results in its phase 2 clinical trials, the company said.

Related Keywords

Taipei ,T Ai Pei ,Taiwan ,Peru ,Argentina ,Liu Sheng Yung ,Chen Yung Chi ,Alan Tseng ,Senhwa Biosciences Inc ,Labcorp Drug Development ,Taipei Exchange On ,Taipei Exchange ,Golden Biotechnology Corp ,Taipei Times ,Kao Shih Ching ,Biotechnology Corp ,Emerging Stock Board ,自由時報 ,Iberty Times Net ,Tn ,